Cargando…

Sex Difference in Spinal Muscular Atrophy Patients – are Males More Vulnerable?

BACKGROUND: Sex is a significant risk factor in many neurodegenerative disorders. A better understanding of the molecular mechanisms behind sex differences could help develop more targeted therapies that would lead to better outcomes. Untreated spinal muscular atrophy (SMA) is the leading genetic mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jianli, Harrington, Melissa A., Porter, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578261/ https://www.ncbi.nlm.nih.gov/pubmed/37393514 http://dx.doi.org/10.3233/JND-230011

Ejemplares similares

The Alteration of Intrinsic Excitability and Synaptic Transmission in Lumbar Spinal Motor Neurons and Interneurons of Severe Spinal Muscular Atrophy Mice
por: Sun, Jianli, et al.
Publicado: (2019)

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

Cerebellar structural, astrocytic, and neuronal abnormalities in the SMNΔ7 mouse model of spinal muscular atrophy
por: Cottam, Nicholas C., et al.
Publicado: (2023)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Spinal Muscular Atrophy Type 3 Showing a Specific Pattern of Selective Vulnerability on Muscle Ultrasound
por: Nakamura, Ryutaro, et al.
Publicado: (2021)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada
por: McMillan, H.J., et al.
Publicado: (2021)

How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?
por: Uher, David, et al.
Publicado: (2023)

Very severe spinal muscular atrophy (Type 0)
por: Al Dakhoul, Suleiman
Publicado: (2017)

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
por: Glascock, Jacqueline, et al.
Publicado: (2023)

Neuromuscular junction pathology is correlated with differential motor unit vulnerability in spinal and bulbar muscular atrophy
por: Molotsky, Elana, et al.
Publicado: (2022)

Cardiac involvement in patients with Spinal Muscular Atrophies
por: Palladino, Alberto, et al.
Publicado: (2011)

Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance
por: Keinath, Melissa C, et al.
Publicado: (2021)

Sex differences in severity and mortality from COVID-19: are males more vulnerable?
por: Pradhan, Ajay, et al.
Publicado: (2020)

Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2020)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
por: Bowerman, Melissa, et al.
Publicado: (2017)

Heterogeneity in spinal muscular atrophy with respiratory distress type 1
por: Majid, Aziz, et al.
Publicado: (2012)

Eighteen Years with Spinal Muscular Atrophy (SMA) Type 1
por: Valencia, Borja, et al.
Publicado: (2013)

Tongue fasciculations in an infant with spinal muscular atrophy type 1
por: Giannopoulou, Eleni Z, et al.
Publicado: (2015)

Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy
por: Boyd, Penelope J., et al.
Publicado: (2017)

Mid1 is associated with androgen-dependent axonal vulnerability of motor neurons in spinal and bulbar muscular atrophy
por: Ogura, Yosuke, et al.
Publicado: (2022)

Rapidly Worsening Bulbar Symptoms in a Patient with Spinobulbar Muscular Atrophy
por: Diaz-Abad, Montserrat, et al.
Publicado: (2013)

Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy
por: Lusakowska, Anna, et al.
Publicado: (2021)

Respiratory muscle fatigability in patients with spinal muscular atrophy
por: Kant‐Smits, Kim, et al.
Publicado: (2022)

Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported Outcomes
por: Dunaway Young, Sally, et al.
Publicado: (2023)

Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy
por: Millino, Caterina, et al.
Publicado: (2009)

Gene therapy for spinal muscular atrophy: the Qatari experience
por: Ali, Hossamaldein Gaber, et al.
Publicado: (2021)

Mitochondrial abnormalities in spinal and bulbar muscular atrophy
por: Ranganathan, Srikanth, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0ecmv9npma4mvp6c2v2e80s33n